Published in Science on June 03, 1988
Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J Virol (1990) 7.85
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol (1993) 4.19
Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J Virol (1991) 3.09
CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol (1989) 2.77
Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J Virol (1992) 2.23
Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci U S A (1988) 2.21
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (2000) 2.16
Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1991) 1.80
Cofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol (1993) 1.71
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. Proc Natl Acad Sci U S A (1989) 1.56
Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding. J Exp Med (1990) 1.44
Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J Virol (1997) 1.41
Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology (2004) 1.38
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. J Virol (1989) 1.38
Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding. J Virol (1991) 1.36
The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev (1995) 1.34
Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc Natl Acad Sci U S A (1989) 1.33
The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein. J Virol (1990) 1.27
Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope. J Virol (1990) 1.27
Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries. J Virol (1999) 1.24
CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells. J Virol (1990) 1.20
Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Proc Natl Acad Sci U S A (1989) 1.19
Antibodies that block rhinovirus attachment map to domain 1 of the major group receptor. J Virol (1990) 1.17
Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. J Exp Med (1989) 1.16
Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol Rev (1996) 1.13
Several CD4 domains can play a role in human immunodeficiency virus infection in cells. J Virol (1991) 1.13
Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 0.94
Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus. Immunology (1990) 0.89
Sequence-specific DNA binding by glucocorticoid receptor "zinc finger peptides". Proc Natl Acad Sci U S A (1990) 0.88
Reduced monomeric CD4 is the preferred receptor for HIV. J Biol Chem (2010) 0.86
Cell-surface expression and purification of human CD4 produced in baculovirus-infected insect cells. Proc Natl Acad Sci U S A (1989) 0.84
The productive entry pathway of HIV-1 in macrophages is dependent on endocytosis through lipid rafts containing CD4. PLoS One (2014) 0.83
Distinct modulatory effects of bryostatin 1 and staurosporine on the biosynthesis and expression of the HIV receptor protein (CD4) by T cells. Cell Regul (1991) 0.82
Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS One (2012) 0.82
Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes. Proc Natl Acad Sci U S A (1992) 0.81
Expression of CD4 by human megakaryocytes. Proc Natl Acad Sci U S A (1990) 0.81
Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4. J Virol (1996) 0.79
Conservation of a polyanion binding site in mammalian and avian CD4. Immunology (1991) 0.77
The T cell antigen receptor CD3:CD4 molecular complex is diminished on the surface of pulmonary lymphocytes. Am J Pathol (1994) 0.77
Flow cytometry analysis of OKT4 epitope deficiency in South African black children. Clin Exp Immunol (1994) 0.75
Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93
A gas-liquid solid phase peptide and protein sequenator. J Biol Chem (1981) 15.73
Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. Methods Enzymol (1983) 12.78
Fluorescence detection in automated DNA sequence analysis. Nature (1986) 12.53
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Synthesis of proteins by native chemical ligation. Science (1994) 10.98
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Timing the ancestor of the HIV-1 pandemic strains. Science (2000) 10.42
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science (1983) 9.06
A cellular gene encodes scrapie PrP 27-30 protein. Cell (1985) 8.86
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc Natl Acad Sci U S A (1983) 8.57
AIDS as a zoonosis: scientific and public health implications. Science (2000) 8.28
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science (1986) 7.81
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. Proc Natl Acad Sci U S A (1987) 7.53
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science (1989) 7.15
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol (2000) 6.71
HIV-1 nomenclature proposal. Science (2000) 6.61
The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu Rev Immunol (1986) 6.23
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
Purification and structural studies of a major scrapie prion protein. Cell (1984) 5.98
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res (1993) 5.82
Recombination in HIV-1. Nature (1995) 5.72
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature (1994) 5.68
Testing for differentially-expressed genes by maximum-likelihood analysis of microarray data. J Comput Biol (2000) 5.52
High-sensitivity sequencing with a gas-phase sequenator. Methods Enzymol (1983) 5.36
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol (1992) 5.19
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci U S A (1985) 5.10
Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 5.02
HIV viral load markers in clinical practice. Nat Med (1996) 4.78
Analysis of phenylthiohydantoins by ultrasensitive gradient high-performance liquid chromatography. Methods Enzymol (1983) 4.60
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
Specific-primer-directed DNA sequencing. Anal Biochem (1986) 4.31
Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev (1988) 4.23
Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol (1992) 4.20
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol (2007) 4.13
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (polybrene), and high pressure liquid chromatography. Biochemistry (1978) 4.10
Miscarriage and use of multi-vitamins or folic acid. Am J Med Genet (2000) 3.95
Recombination in AIDS viruses. J Mol Evol (1995) 3.94
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A (1999) 3.91
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Synthesis of native proteins by chemical ligation. Annu Rev Biochem (2000) 3.81
Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem (1981) 3.70
DNA sequences mediating class switching in alpha-immunoglobulins. Science (1980) 3.70
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65
The synthesis of oligonucleotides containing an aliphatic amino group at the 5' terminus: synthesis of fluorescent DNA primers for use in DNA sequence analysis. Nucleic Acids Res (1985) 3.63
Virus dynamics and drug therapy. Proc Natl Acad Sci U S A (1997) 3.63
Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science (1984) 3.62
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med (1998) 3.61
Acetylcholine receptor: complex of homologous subunits. Science (1980) 3.45
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Electroblotting onto activated glass. High efficiency preparation of proteins from analytical sodium dodecyl sulfate-polyacrylamide gels for direct sequence analysis. J Biol Chem (1986) 3.33
A novel and ubiquitous system for membrane targeting and secretion of cofactor-containing proteins. Cell (1998) 3.33
Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci U S A (1983) 3.21
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19
Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med (1998) 3.19
Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell (1986) 3.11
The origins of acquired immune deficiency syndrome viruses: where and when? Philos Trans R Soc Lond B Biol Sci (2001) 3.10